Partnership Opportunities

Partner with us

Partnering with the 3rd CKD3 is your opportunity to elevate your company’s standing as 2020 marks a new wave of excitement and opportunity for pipelines active in chronic glomerular disease.

Your brand, your message, your reputation showcased in front of the leading minds pioneering more innovative, targeted and clinically successful drug development for FSGS, IgA, PKD, DKD, C3G, LN, and Alport’s syndrome.

Whether you’re on the brink of validating your approach and need to communicate this exciting progress or you’re simply looking to generate leads, put names to faces or get a grasp of the new excitement 2020 has brought; you can rely on our ability to advise on, and deliver, the right solution for you.

Contact us today to learn how we can help you achieve your business goals faster, more effectively, and more cost-efficiently, contact us today at


Industry of attendees
Job titles of attendees

Snapshot of Previous Attending Companies:

Daiichi Sankyo Co. Ltd.
Goldfinch Biopharma Inc.
Inception Sciences
Ionis Pharmaceuticals
Johnson & Johnson
Merck & Co
Reata Pharmaceuticals
Regeneron Pharmaceuticals
The Broad Institute of MIT & Harvard
Vertex Pharmaceuticals
Vifor Pharma

“Great opportunity where I made over 10 key contacts that would not have been made otherwise. Progressed one key collaboration already!"

ACEA Bioscience

"Good representation of pharma, biotech, CRO and regulatory colleagues, which lead to stimulating conversations and presentations on: pathophysiology, potential targets, challenges involved in clinical studies and developing regulatory and payer perspectives."


"Great event, exceptional networking opportunities. High quality of presentations. Very efficient way to spend my time "


"It's a 'small' forum where the business of science can be openly discussed. Intimate and focused "

Syneos Health